Maxim analyst Naz Rahman downgraded Processa Pharmaceuticals to Hold from Buy.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PCSA:
- Processa Pharmaceuticals, Inc. Mourns the Sudden Passing of Board Member Virgil Thompson
- Processa Pharmaceuticals to Present at the 20th Orphan Drugs and Rare Diseases Global Congress 2023 Americas
- Processa Pharmaceuticals announces formation of Oncology Advisory Board
- Processa Pharmaceuticals Announces Formation of Oncology Advisory Board with Renowned Key Opinion Leaders
- Processa Pharmaceuticals to Present at the ThinkEquity Conference